Immune Systems Advisor

The McCairn Protocol (Edogawa–McCairn Protocol): Overview and Mechanistic Rationale The McCairn Protocol (also referred to as the Edogawa–McCairn Protocol ) is an experimental, two-phase treatment approach promoted by Kevin McCairn in collaboration with Edogawa Hospital. It is primarily proposed for individuals with Long COVID and post-mRNA vaccine–associated syndromes , targeting hypothesized drivers such as persistent spike protein, amyloid-like fibrin microclots, autoantibodies, chronic inflammation, and associated vascular or neurological dysfunction. Phase 1: Double Filtration Plasmapheresis (DFPP) / Plasma Adsorption (“Cleansing”) Double Filtration Plasmapheresis (DFPP) is a specialized form of therapeutic apheresis currently used in parts of Asia, including Japan, for selected autoimmune, neurological, and metabolic conditions. Procedure Blood is withdrawn, often via a large-bore catheter (e.g., internal jugular access). It is passed through a dual-filtration syste...

Updates:  COVID-19 Vaccine Labels Updated With Expanded Warnings About Risk of Heart Inflammation (June 2025) COVID-19 Vaccine Myocarditis More Common and More Severe Than SARS-CoV-2 Infection Myocarditis: Landmark Study (2025) Stanford Study Pinpoints Cause of Vaccine-Linked Myocarditis and a Possible Fix (Dec 2025) Damage to the heart is more common than thought after receipt of Moderna’s COVID-19 booster, a  July 2023 study  indicates. One in 35 health care workers at a Swiss hospital had signs of heart injury associated with the vaccine, mRNA-1273, researchers found. “mRNA-1273 booster vaccination-associated elevation of markers of myocardial injury occurred in about one out of 35 persons (2.8%), a greater incidence than estimated in meta-analyses of hospitalized cases with myocarditis (estimated incidence 0.0035%) after the second vaccination,” the researchers wrote in the paper, published by the European Journal of Heart Failure. In a generally healthy population...

Clinical Therapeutics & Review Papers OneDayMD Clinical Review Team • Published Collaboratively • Updated: June 2026 Abstract The persistence of the SARS-CoV-2 spike protein within human tissue post-acute infection or via repeat genetic vaccination has emerged as a focal point in the pathology of Long COVID (Post-Acute Sequelae of COVID-19) and associated multi-system immune injuries. This review analyzes the clinical rationale behind the "Base Spike Detox" protocol pioneered by Dr. Peter McCullough, MD, MPH. The protocol deploys a triple oral combination of oral nattokinase, bromelain, and nano/liposomal curcumin to accelerate the systemic breakdown and clearance of persistent spike antigens. We evaluate the proteolytic (protein-breaking), fibrinolytic (clot-dissolving), and anti-inflammatory mechanisms of these over-the-counter agents, review preliminary real-world evidence, outlin...

Summary: Emerging studies and Senate testimony have raised questions about possible links between mRNA vaccination, spike protein biology, and aggressive cancer progression. However, major health agencies continue to state that current evidence does not establish a causal relationship, highlighting the need for further independent research. The medical community is currently engaged in a rigorous debate regarding a phenomenon colloquially termed "turbo cancer"—a clinical shorthand for malignancies that appear suddenly, grow with unexpected speed, and present at advanced stages in younger populations. While mainstream health organizations often classify these reports as unsubstantiated, a series of 2025 and 2026 studies, along with high-level Senate testimony, have brought new evidence to the forefront regarding the potential oncogenic risks of COVID-19 mRNA vaccine platforms. Editor's note: The term "turbo cancer" is not a recognized medical diagnosis and that ...